A prognostic indicator for the resection of liver metastasis of colorectal cancer

被引:19
作者
Amano, Ryosuke [1 ]
Yamada, Nobuya [1 ]
Nakata, Bunzo [1 ]
Kimura, Kenjiro [1 ]
Yashiro, Masakazu [1 ,2 ]
Ohira, Masaichi [1 ]
Hirakawa, Kosei [1 ]
机构
[1] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka 5458585, Japan
[2] Osaka City Univ, Grad Sch Med, Oncol Inst Geriatr & Med Sci, Osaka 5458585, Japan
关键词
Liver metastasis of colorectal cancer; Grade classification; JCCRC; MULTICENTER RANDOMIZED-TRIAL; LONG-TERM SURVIVAL; HEPATIC RESECTION; COLON-CANCER; PHASE-III; FLUOROURACIL; CHEMOTHERAPY; OXALIPLATIN; LEUCOVORIN; IRINOTECAN;
D O I
10.1007/s00595-013-0699-x
中图分类号
R61 [外科手术学];
学科分类号
摘要
We investigated the predictive indicator for a good prognosis of surgical resection for liver metastasis of colorectal cancer. Between 1990 and 2009 at our institute, 117 patients underwent 132 hepatic resections for liver metastasis of colorectal cancer. The clinical, pathological, and outcome parameters affecting their prognoses were analyzed. The extent of the liver metastases was subdivided according to the Japanese Classification of Colorectal Carcinoma (JCCRC), and the patients were classified into different grades based on the JCCRC classification and the status of the nodal involvement of the primary tumor. The median survival time (MST) of the 117 patients was 58 months, and the actuarial survival rates at 1, 3, and 5 years were 92.3, 60.0, and 46.1 %, respectively. A multivariate analysis revealed that the JCCRC Grade classification was an independent prognostic indicator (Grade A vs. B vs. C: MST, 72 vs. 41 vs. 23 months; 5-year survival, 59.0 vs. 38.6 vs. 0 %: p < 0.0001). Our findings indicate that the JCCRC Grade classification for liver metastasis of colorectal cancer is a significant prognostic indicator and may be useful for making decisions regarding the treatment of liver metastasis.
引用
收藏
页码:1287 / 1292
页数:6
相关论文
共 34 条
  • [1] Adam R, 2001, ANN SURG ONCOL, V8, P347
  • [2] Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?
    Adam, Rene
    de Haas, Robbert J.
    Wicherts, Dennis A.
    Aloia, Thomas A.
    Delvart, Valerie
    Azoulay, Daniel
    Bismuth, Henri
    Castaing, Denis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) : 3672 - 3680
  • [3] Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
    Andre, T
    Boni, C
    Mounedji-Boudiaf, L
    Navarro, M
    Tabernero, J
    Hickish, T
    Topham, C
    Zaninelli, M
    Clingan, P
    Bridgewater, J
    Tabah-Fisch, I
    de Gramont, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) : 2343 - 2351
  • [4] Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin
    Aoki, Taku
    Umekita, Nobutaka
    Tanaka, Soichi
    Noda, Kazumasa
    Warabi, Masahiro
    Kitamura, Masatsugu
    [J]. SURGERY, 2008, 143 (06) : 706 - 714
  • [5] Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer
    Arru, Marcella
    Aldrighetti, Luca
    Castoldi, Renato
    Di Palo, Saverio
    Orsenigo, Elena
    Stella, Marco
    Pulitano, Carlo
    Gavazzi, Francesca
    Ferla, Gianfranco
    Di Carlo, Valerio
    Staudacher, Carlo
    [J]. WORLD JOURNAL OF SURGERY, 2008, 32 (01) : 93 - 103
  • [6] BENGMARK S, 1969, CANCER, V23, P198, DOI 10.1002/1097-0142(196901)23:1<198::AID-CNCR2820230126>3.0.CO
  • [7] 2-J
  • [8] A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery
    Beppu, Toru
    Sakamoto, Yoshihiro
    Hasegawa, Kiyoshi
    Honda, Goro
    Tanaka, Kuniya
    Kotera, Yoshihito
    Nitta, Hiroyuki
    Yoshidome, Hiroyuki
    Hatano, Etsuro
    Ueno, Masaki
    Takamura, Hiroyuki
    Baba, Hideo
    Kosuge, Tomoo
    Kokudo, Norihiro
    Takahashi, Keiichi
    Endo, Itaru
    Wakabayashi, Go
    Miyazaki, Masaru
    Uemoto, Shinji
    Ohta, Tetsuo
    Kikuchi, Ken
    Yamaue, Hiroki
    Yamamoto, Masakazu
    Takada, Tadahiro
    [J]. JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2012, 19 (01) : 72 - 84
  • [9] Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
    Douillard, JY
    Cunningham, D
    Roth, AD
    Navarro, M
    James, RD
    Karasek, P
    Jandik, P
    Iveson, T
    Carmichael, J
    Alakl, M
    Gruia, G
    Awad, L
    Rougier, P
    [J]. LANCET, 2000, 355 (9209) : 1041 - 1047
  • [10] Fong Y, 1996, SEMIN SURG ONCOL, V12, P219, DOI 10.1002/(SICI)1098-2388(199607/08)12:4<219::AID-SSU3>3.3.CO